Literature DB >> 11886005

Very young women (<35 years) with operable breast cancer: features of disease at presentation.

M Colleoni1, N Rotmensz, C Robertson, L Orlando, G Viale, G Renne, A Luini, P Veronesi, M Intra, R Orecchia, G Catalano, V Galimberti, F Nolé, G Martinelli, A Goldhirsch.   

Abstract

BACKGROUND: Breast cancer rarely occurs in young women. Our knowledge about disease presentation, prognosis and treatment effects are largely dependent upon older series.
MATERIALS AND METHODS: We evaluated biological features and stage at presentation for 1427 consecutive premenopausal patients aged < or = 50 years with first diagnosis of invasive breast cancer referred to surgery at the European Institute of Oncology from April 1997 to August 2000. A total of 185 patients (13%) were aged < 35 years ('very young') and 1242 (87%) were aged 35-50 years ('less young'). The expression of estrogen receptors (ER), progesterone receptors (PgR), presence of vascular invasion (VI), grading (G), expression of Ki-67, HER2/neu overexpression, pathological stage according to TNM staging system (pTNM), pathological tumor size and number of axillary lymph node involvement were evaluated.
RESULTS: Compared with less young patients, the very young patient group had a higher percentage of tumors classified as ER negative (P < 0.001), PgR negative (P = 0.001), higher expression of Ki-67 > or = 20% of cells stained; 62.2% versus 53%, (P < 0.001), vascular or lymphatic invasion (48.6% versus 37.3%, P = 0.006), and pathological grade 3 (P < 0.0001). There was no difference between the two groups for pT, pathological tumor size (pN) and number of positive lymph nodes.
CONCLUSIONS: We conclude that compared with less young premenopausal patients, very young women have a greater chance of having an endocrine-unresponsive tumor, and are more likely to present with a higher grade, more extensively proliferating and vessel invading disease. Pathological tumor size, nodal status and number of positive axillary lymph-nodes have a similar distribution among the younger and the older cohorts, thus not supporting previous data indicating more advanced disease in younger patients at diagnosis of operable disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11886005     DOI: 10.1093/annonc/mdf039

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  102 in total

1.  Prognosis in very young women with triple-negative breast cancer: retrospective study of 216 cases.

Authors:  Ying Liu; Tao Xin; Da-yong Huang; Wei-xi Shen; Li Li; Yan-ju Lv; Ying-hua Jin; Xiao-wei Song; Chong Teng; Qiu-ying Jiang
Journal:  Med Oncol       Date:  2014-11-13       Impact factor: 3.064

2.  Effects of Age and Immune Landscape on Outcome in HER2-Positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials.

Authors:  Saranya Chumsri; Daniel J Serie; Zhuo Li; Katherine L Pogue-Geile; Aixa E Soyano-Muller; Afshin Mashadi-Hossein; Sarah Warren; Yanyan Lou; Gerardo Colon-Otero; Keith L Knutson; Edith A Perez; Alvaro Moreno-Aspitia; E Aubrey Thompson
Journal:  Clin Cancer Res       Date:  2019-02-26       Impact factor: 12.531

3.  Defining a comprehensive verotype using electronic health records for personalized medicine.

Authors:  Mary Regina Boland; George Hripcsak; Yufeng Shen; Wendy K Chung; Chunhua Weng
Journal:  J Am Med Inform Assoc       Date:  2013-09-03       Impact factor: 4.497

4.  Breast cancer tumor histopathology, stage at presentation, and treatment in the extremes of age.

Authors:  Jennifer K Plichta; Samantha M Thomas; Rebecca Vernon; Oluwadamilola M Fayanju; Laura H Rosenberger; Terry Hyslop; E Shelley Hwang; Rachel A Greenup
Journal:  Breast Cancer Res Treat       Date:  2020-01-24       Impact factor: 4.872

Review 5.  Breast cancer in an 18-year-old female: A fatal case report and literature review.

Authors:  Maciej Jóźwik; Renata Posmyk; Marcin Jóźwik; Andrzej Semczuk; Magdalena Gogiel-Shields; Marta Kuś-Słowińska; Magdalena Garbowicz; Mark Klukowski; Jacek Wojciechowicz
Journal:  Cancer Biol Ther       Date:  2018-07-03       Impact factor: 4.742

6.  Breast carcinoma in a prepubertal girl.

Authors:  Syed Tausif Ahmed; Sudipto Kumar Singh; Tanmoy Mukherjee; Manju Banerjee
Journal:  BMJ Case Rep       Date:  2014-04-15

7.  Risk factors and natural history of breast cancer in younger Chinese women.

Authors:  Winnie Yeo; Hang-Mei Lee; Amy Chan; Emily Yy Chan; Miranda Cm Chan; Keeng-Wai Chan; Sharon Ww Chan; Foon-Yiu Cheung; Polly Sy Cheung; Peter Hk Choi; Josette Sy Chor; William Wl Foo; Wing-Hong Kwan; Stephen Ck Law; Lawrence Pk Li; Janice Wh Tsang; Yuk Tung; Lorna Ls Wong; Ting-Ting Wong; Chun-Chung Yau; Tsz-Kok Yau; Benny Cy Zee
Journal:  World J Clin Oncol       Date:  2014-12-10

8.  Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an East Asian country: a nationwide cancer registry-based study.

Authors:  Ching-Hung Lin; Po-Ya Chuang; Chun-Ju Chiang; Yen-Shen Lu; Ann-Lii Cheng; Wen-Hung Kuo; Chiun-Sheng Huang; Mei-Shu Lai; San-Lin You; Chao-Hsiun Tang
Journal:  Oncologist       Date:  2014-05-07

Review 9.  Breast cancer in young women and its impact on reproductive function.

Authors:  M Hickey; M Peate; C M Saunders; M Friedlander
Journal:  Hum Reprod Update       Date:  2009-01-27       Impact factor: 15.610

10.  Breast cancer in young women: poor survival despite intensive treatment.

Authors:  Hanna Fredholm; Sonja Eaker; Jan Frisell; Lars Holmberg; Irma Fredriksson; Henrik Lindman
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.